Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Peyronie's disease (PD) is a wound-healing disorder of the tunica albuginea of the penis which affects 3-9% of adult males. Clinically, any combination of plaque formation, penile pain, angulation and erectile dysfunction may appear. This condition may progress, stabilize or, uncommonly, regress during the initial acute phase (6-18 months). AREAS COVERED: Information regarding this review was searched in PubMed until August 2010. Vitamin E, paraaminobenzoate and colchicine are sparingly employed oral medical therapies. Intralesional injections as a minimally invasive therapy for PD includes injection with verapamil, interferon-α-2b, and collagenase. Men suffering with PD who have significant penile deformity precluding successful coitus can be appraised for surgical correction. Surgery is considered the gold standard and includes plication, incision and grafting- or penile-prosthesis-related procedures. EXPERT OPINION: This paper provides a broad overview of the subject of PD, available nonsurgical options and surgical approaches that will aid in the routine clinical diagnosis and management of PD. Increased public and medical awareness of PD prevalence, presentation, diagnosis and treatment options will serve well the large population of men who suffer in silence with this common condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El-Sakka, A. I., Hassoba, H. M., Pillarisetty, R. J., Dahiya, R., & Lue, T. F. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64223-x · Cited by 250 · cited 1×
“Certain cytokines, TGF-b and fibroblast growth factor (FGF) play important roles in the development of PD [105-107].”
BackgroundMechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease
Gonzalez-Cadavid, N. F., & Rajfer, J. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0201 · Cited by 168 · cited 3×
“Oral Vitamin E Scavenges free radical Reduces scarring process and decreases fibrosis caused by free radical damage [9,15]”
BackgroundInfluentialDuncan, M. R., Berman, B., & Nseyo, U. O. (1991) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599109024539 · Cited by 132 · cited 1×
“The interest in IFN-a-2b arose from in vitro experiments that demonstrated a decreased production of extracellular matrix collagen and increased collagenase in fibroblasts derived from Peyronie’s plaques [46,47].”
BackgroundPeyronie’s Disease Intervention Trials: Methodological Challenges and Issues
Müller, A., & Mulhall, J. P. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01081.x · Cited by 80 · cited 1×
“Recent studies have documented that in 10 -- 15% of men with PD, the condition will resolve spontaneously over 1 year after the diagnosis is made, with 40% remaining the same and approximately 45% progressing [4,5].”
BackgroundHaag, S. M., Hauck, E. W., Szardening-Kirchner, C., Diemer, T., Cha, E.-S., Weidner, W., & Eickelberg, O. (2007) · European Urology · doi:10.1016/j.eururo.2006.05.002 · Cited by 74
Ryu, J.-K., Piao, S., Shin, H.-Y., Choi, M. J., Zhang, L. W., Jin, H.-R., Kim, W. J., Han, J.-Y., Hong, S. S., Park, S. H., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01216.x · Cited by 48
Lin, C.-S., Lin, G., Wang, Z., Maddah, S. A., & Lue, T. F. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00765-9 · Cited by 45
Radiation Increases Fibrogenic Cytokine Expression by Peyronie’s Disease Fibroblasts
MULHALL, J. P., BRANCH, J., LUBRANO, T., & SHANKEY, T. V. (2003) · Journal of Urology · doi:10.1097/01.ju.0000070860.78370.08 · Cited by 22
Cited by
Hellstrom, W. J. G., Feldman, R., Rosen, R. C., Smith, T., Kaufman, G., & Tursi, J. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.01.090 · Cited by 210
Self-citationOutcomes of surgical treatment of Peyronie's disease
Carson, C. C., & Levine, L. A. (2014) · BJU International · doi:10.1111/bju.12565 · Cited by 82
Understanding the course of Peyronie's disease
Garaffa, G., Trost, L. W., Serefoglu, E. C., Ralph, D., & Hellstrom, W. J. G. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12129 · Cited by 75
Self-citationYang, C.-H., Lin, D.-Y., Lin, Y.-S., Hsu, C.-Y., Tung, M.-C., Tan, K.-T., & Ou, Y.-C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010777 · Cited by 7
“Thus, intra‐lesion injection of corticosteroids was not recommended based on the current literature [77].”
Background
Metadata
- Authors
- Gur, S., Limin, M., & Hellstrom, W. J.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa Healthcare
- Published
- 2011-03-15
- Volume
- 12
- Issue
- 6
- Pages
- 931-944
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W2162323812
- Cited by
- 75
- References
- 8
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options. https://app.cochat.ai/papers/10.1517/14656566.2011.544252
- The paper
- Gur, S., Limin, M., & Hellstrom, W. J. (2011). Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options. Expert Opinion on Pharmacotherapy. https://doi.org/10.1517/14656566.2011.544252
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.